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Abstract
Background: One of the main determinants of public immunization success is health professionals' support and 
recommendations. Little is known about the physicians' level of support and intentions regarding A(H1N1) pandemic 
influenza vaccination. The aim of this survey was to document Canadian family physicians' and paediatricians' 
knowledge, attitudes and practices (KAP) as well as their intentions regarding A(H1N1) pandemic influenza vaccines 
right before the beginning of the largest immunization campaign in Canadian history.
Findings: A self-administered, anonymous, mail-based questionnaire was sent to a random sample of family 
physicians and to all paediatricians practicing in Canada. All 921 questionnaires received by October 29 2009 were 
included in the analysis. Between 72% and 92% of respondents agreed with the statements regarding vaccine safety, 
effectiveness and acceptability. More than 75% of respondents intended to recommend the A(H1N1) pandemic 
influenza vaccine to their patients and to get vaccinated themselves. The most significant factors associated with the 
intention to recommend A(H1N1) pandemic vaccines were physicians' intention to be vaccinated against influenza 
themselves and the perceived acceptability of the vaccine by the vaccinators.
Conclusions: Most Canadian family physicians and paediatricians surveyed were supportive of the A(H1N1) pandemic 
influenza vaccination before its implementation and large media coverage.
Findings
In June 2009, the World Health Organization declared an
influenza A(H1N1) pandemic[1]. Modelling studies have
shown that vaccination is the most effective intervention
in reducing A(H1N1) pandemic influenza morbidity, hos-
pitalisation, and mortality [2-4]. It is commonly recog-
nized that the results of an immunization campaign are
determined by vaccine characteristics, vaccination cam-
paign timelines and vaccine uptake. However, the success
of a new vaccination campaign should not be taken for
granted and public acceptance of a new vaccine should
not be assumed [5-7]. Health professionals are known to
be the most trusted source of information about vaccina-
tion in Canada [8] and their recommendation is one of
the main determinants of vaccine uptake [9-11]. Both
family physicians and paediatricians are involved in rou-
tine vaccine delivery and are expected to play a major role
in emerging pandemic vaccination campaigns. However,
very little data exist about their acceptance of a pandemic
vaccine and, to our knowledge, no systematically col-
lected data regarding physician knowledge, attitudes and
practice (KAP) on A(H1N1) pandemic vaccine have been
reported.
The main aim of this paper is to document Canadian
family physicians' and paediatricians' KAP regarding
A(H1N1) pandemic influenza and its prevention by vac-
cination prior to vaccine approval for clinical use and
large media coverage of the immunization campaign.
Methods
A self-administered, anonymous, mail-based question-
naire was sent between August 20 and September 30
2009 to a random sample of 1182 family physicians and to
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Directory [12] was used to identify paediatricians and to
obtain a random sample of family physicians. This data-
base contains more than 58 000 listings of medical con-
tact information and is updated each year. Based on the
analytical framework for immunization programs in Can-
ada [13], the first section of the questionnaire addressed
the respondents' KAP regarding routinely used and newly
available or candidate vaccines in Canada, including the
A(H1N1) pandemic vaccine. Respondents were asked to
base their answers on their own knowledge and opinion.
No information on A(H1N1) pandemic influenza infec-
tion or the vaccine was provided. Descriptive statistics
were generated for all variables. Multivariate logistic
regressions models were used to determine variables inde-
pendently associated with the intention to recommend the
A(H1N1) pandemic vaccine. Dependent variables were
dichotomized: the responses "strongly agree" and "agree"
versus all others. Missing responses were excluded from
the analysis. Variables associated in the univariate analysis
with the intention to recommend the vaccine at p ≤ 0.20
were entered into the multivariate regression models using
the stepwise selection technique. Variables were reevalu-
ated in the final model to check for confounding and




Somewhat Disagree Somewhat Agree Agree/Strongly 
Agree
Family Physicans (n = 207)*
A(H1N1) pandemic influenza ...
Is a serious disease 4% 10% 32% 49%
Would occur frequently in 
Canada without vaccination
8% 10% 26% 52%
Generate a significant 
economic burden in Canada
4% 5% 17% 69%
A(H1N1) pandemic influenza 
vaccine will be...
Safe 5% 10% 35% 38%
Effective 4% 9% 46% 26%
Well accepted by the public 6% 17% 35% 38%
Well accepted by vaccinators 3% 8% 26% 58%
I will recommend A(H1N1) 
pandemic vaccine to my 
patients
1% 6% 20% 68%
Paediatricians (n = 714)*
A(H1N1) pandemic influenza ...
Is a serious disease 3% 6% 27% 59%
Would occur frequently in 
Canada without vaccination
6% 6% 24% 59%
Generate a significant 
economic burden in Canada
2% 3% 15% 77%
A(H1N1) pandemic influenza 
vaccine will be...
Safe 2% 6% 36% 43%
Effective 3% 6% 45% 28%
Well accepted by the public 5% 13% 34% 42%
Well accepted by vaccinators 2% 4% 21% 67%
I will recommend A(H1N1) 
pandemic vaccine to my 
patients
2% 3% 15% 75%
*Due to missing responses, row percentages may not add up to 100%.
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sided tests was considered statistically significant. The col-
linearity was checked and the adequacy of the model was
evaluated by Hosmer and Lemeshow's goodness of fit test.
The Statistical Analysis Systems (SAS) software (version
9.1) was used for statistical analysis. The study protocol
was approved by the Ethics Board of the Laval University
Hospital Center (reference number 126.05.02).
The A(H1N1) pandemic vaccine was approved in Can-
ada at the end of October 2009. Due to important educa-
tional efforts undertaken afterwards and their potential
impact on physicians' KAB, we have decided to perform
two separate analyses. Only questionnaires received
before October 29 2009 were included in this analysis.
Participation
This study is ongoing. All 921 questionnaires received by
October 29 2009, after the first questionnaire mailing,
were included in this report. After exclusion of 208 physi-
cians no longer practicing or with wrong addresses, the
overall participation rate was 31% (18% for family physi-
cians and 39% for paediatricians). Of the 207 family phy-
sicians who managed to complete the survey by October
29 2009, 64% spent more than 21 hours a week in outpa-
tient consultation, 51% were men and 58% had been prac-
ticing medicine for 20 years or longer. Of the 714
paediatricians who managed to complete the survey by
October 29 2009, 52% spent more than 21 hours a week
in outpatient consultation, 42% were men and 46% had
been practicing for 20 years or longer. Eighty seven per-
cent of family physicians and 59% of paediatricians stated
that vaccines were administered at their main practice.
Knowledge, attitudes and practices regarding A(H1N1) 
pandemic influenza and its prevention by vaccination
One third of family physicians (33%) and almost half of
the paediatricians (46%) had had experience with
A(H1N1) pandemic influenza disease before responding
to this survey. Overall, 82% of family physicians and 88%
of paediatricians estimated that "A(H1N1) pandemic
influenza is severe enough to take special precautions to
prevent it".
Approximately 80% of both family physicians and paedi-
atricians perceived A(H1N1) pandemic infection as a seri-
ous disease, that would occur frequently without
vaccination (Table 1). Thirty seven percent of family physi-
cians and 45% of paediatricians strongly agreed that
A(H1N1) generates a significant economic burden in Can-
ada. From 72% to 79% of respondents agreed with the
statements regarding the usefulness and safety of the
A(H1N1) pandemic influenza vaccines. Comparatively,
52% of family physicians and 72% of paediatricians agreed
or strongly agreed that seasonal influenza vaccines are very
useful to protect children's health. More than 70% of family
physicians and paediatricians considered that the
A(H1N1) pandemic vaccine would be well accepted by the
public and more than 80% that it would be well accepted by
the vaccinators. The majority of family physicians (88%)
and paediatricians (90%) intended to recommend the
A(H1N1) pandemic influenza vaccine to their patients:
30% of family physicians and 43% of paediatricians stated
that they would strongly recommend it. When recom-
mending new vaccines, 38% of family physicians and 54%
of pediatricians stated being highly influenced by recom-
mendations made by professionals associations. Seventy-
seven percent (77%) of family physicians and 83% of paedi-
atricians intended to get vaccinated against A(H1N1) pan-
demic influenza themselves while 15% of family physicians
and 13% of paediatricians were undecided.
Finally, 47% of family physicians and 36% of paediatri-
cians considered that their knowledge on the A(H1N1)
pandemic influenza vaccine was insufficient, while 28%
of family physicians and 30% of paediatricians considered
it to be somewhat sufficient.
Table 2: Variables associated with respondents intention to recommend A(H1N1) pandemic vaccine*
Variables OR 95% CI P value
Respondents intention to receive A(H1N1) pandemic vaccine 7.81 4.32-14.14 <0.0001
Belief§ that A(H1N1) pandemic vaccine will be well accepted by vaccinators 6.41 3.89-10.58 <0.0001
Belief§ that A(H1N1) pandemic influenza generate a significant economic burden in 
Canada
3.28 1.92-5.61 <0.0001
Being influenced by recommendations made by professionals associations when 
recommending new vaccines
2.32 1.15-4.68 0.02
Belief§ that A(H1N1) pandemic influenza vaccine will be safe 2.30 1.33-3.98 0.003
Belief§ that A(H1N1) pandemic influenza is a serious disease 2.12 1.25-3.57 0.005
Belief§ that seasonal influenza vaccines are very useful to protect children health 2.01 1.21-3.34 0.007
* Multivariate analyses; OR = odds ratio; CI = confidence interval
§ Strongly agree, agree, somewhat agree
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pandemic vaccines
In multivariate analyses, the most significant factors asso-
ciated with respondents' intention to recommend the
A(H1N1) pandemic vaccine were: intention to get vacci-
nated against A(H1N1) pandemic influenza themselves;
belief that A(H1N1) pandemic vaccine would be well
accepted by the vaccinators; perceived safety of the
A(H1N1) pandemic vaccine; belief that A(H1N1) pan-
demic influenza generates a significant health and eco-
nomic burden; perceived usefulness of seasonal influenza
vaccination and compliance with professional associa-
tions' recommendations when recommending new vac-
cines (Table 2).
Interpretation
This survey was conducted at a time when relatively little
information about the characteristics of the second wave
of A(H1N1) pandemic influenza was available and when
very limited data about the new A(H1N1) pandemic vac-
cines' immunogenicity and safety was disclosed. How-
ever, more than one out of three respondents had had
some experience with cases of A(H1N1) pandemic influ-
enza and the majority of them were willing to recom-
mend the A(H1N1) pandemic vaccine to their patients.
More than 75% of the respondents also indicated a will-
ingness to get the vaccine themselves. This proportion is
high when compared to the 26% to 61% vaccination cov-
erage rates for seasonal influenza among healthcare
workers reported in a recent Canadian study [14].
Few studies have been done to assess healthcare profes-
sionals' KAP regarding pandemic influenza and its pre-
vention by immunization [15-17]. Results of an
Australian survey conducted in 2007 with a convenience
sample of clinical and non-clinical healthcare workers
indicated that 86.8% of medical staff respondents consid-
ered that a pandemic influenza would be "very serious" if
one was to occur. The majority of healthcare workers sur-
veyed in 2007 (77.5%) believed that the vaccine would
protect them against pandemic influenza [16]. Results of
another survey conducted in May 2009 with 389 hospital
healthcare workers (mainly nurses) in Hong Kong indi-
cated that 47.9% of them intended to accept A(H1N1)
pandemic vaccination [15].
One internet survey done in April-May 2009 in Canada
reported that 32% of the 213 general practitioners sur-
veyed considered A(H1N1) infection to be a serious or
extremely serious disease [17]. Four months later, 49% of
family physicians and 59% of paediatricians who partici-
pated in our survey agreed or strongly agreed that the
A(H1N1) pandemic infection was a serious disease (addi-
tional 27% to 32% somewhat agreed). Changes in health
professionals' perceived seriousness of a pandemic dis-
ease might be explained by additional information
received and by policy development regarding A(H1N1)
influenza prevention over the summer of 2009.
It is of note that physicians' intention to get the vaccine
for themselves and the perceived acceptability of the
A(H1N1) pandemic vaccine by the vaccinators are the
factors the most strongly associated with the intention to
recommend the vaccine to their patients. Several studies
have shown that the support of an immunization strategy
by vaccinators is perceived as a crucial element in health
professionals' intention to adhere to it [13,18,19].
Beliefs that A(H1N1) pandemic influenza generates a
significant economic burden, beliefs that A(H1N1) pan-
demic influenza is a serious disease, as well as beliefs in
the safety of the A(H1N1) pandemic vaccine, were associ-
ated with physicians' intention to recommend the
A(H1N1) pandemic vaccine. However, this association
was unexpectedly lower when compared to the perceived
acceptability of vaccine by vaccinators and personal
intention to be vaccinated. Finally, the influence of rec-
ommendations made by professional associations on phy-
sicians' intention to recommend a new vaccine is
consistent with results of previous studies [20-22].
This study has several limitations. First, as in most
health professionals' surveys, there is a potential for non
participation bias and socially desirable responses. The
analysis was limited to the time period before the
approval of A(H1N1) pandemic vaccines in Canada and
only responses received by October 29 2009 were
included. Participation rate for this time period was rela-
tively low. However, respondents' demographics and pro-
fessional characteristics were similar to recent studies
with higher response rates conducted in Canadian family
physicians and paediatricians [23-25]. The fact that the
questionnaire was anonymous should also diminish
socially desirable responses. Second, this study was con-
ducted before the federal government announced the
approval of the A(H1N1) pandemic influenza vaccine and
attitudes may have changed after that, as demonstrated in
a recent UK study [26]. In the latest study in healthcare
workers, more respondents indicated willingness to
accept stockpiled H5N1 vaccine during a period of high
media coverage due to an H5N1 outbreak at a commer-
cial poultry farm than after (63.4%, vs. 51.9%; p = 0.009)
[26]. In our survey, between 12% and 15% of respondents
did not answer to statements regarding A(H1N1) pan-
demic influenza vaccine safety and efficacy. This high
level of missing responses, as well as the high proportion
of relatively neutral answers, is due in our opinion to the
respondents' perceived lack of information on these
issues. Finally, the question regarding respondents' inten-
tion to recommend A(H1N1) pandemic vaccine did not
specify the patients' age groups (children versus adults).
In our opinion, this could explain, at least partially, some
differences observed between family physicians' and pae-
Dubé et al. BMC Research Notes 2010, 3:102
http://www.biomedcentral.com/1756-0500/3/102
Page 5 of 5diatricians' intentions to recommend A(H1N1) pandemic
vaccine.
In summary, most Canadian family physicians and pae-
diatricians surveyed were supportive of A(H1N1) pan-
demic influenza vaccination before its implementation
and large media coverage. The next phase of the survey
was launched one month after the implementation of
A(H1N1) pandemic influenza vaccination in Canada.
Results of this first phase provide baseline data to serve as
comparison for data collected during the vaccination
campaign. Analysis of the responses received after Octo-
ber 29 2009 will give us the opportunity to explore the
effect of A(H1N1) pandemic vaccine approval as well as
additional dissemination of information, including pro-
fessional associations' recommendations, on physicians'
KAP regarding pandemic influenza and its prevention by
vaccination.
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